Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (841)
2023 (887)
2022 (831)
2021 (892)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (244)
2011 (163)
2010 (139)
2000 (2)
1977 (2)
All (8488)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Vallianatou T
JSON
CSV
XLSX
TXT
Family name
Vallianatou
Given name
Theodosia
Initials
T
ORCID
ORCID
0000-0002-1477-7756
Affiliations
Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
6 publications
PubMed
DOI
Crossref
Applying Spatial Metabolomics To Investigate Age- and Drug-Induced Neurochemical Changes.
Vallianatou T
,
Angerer TB
, Kaya I, ..., Svenningsson P,
Andrén PE
ACS Chem Neurosci
15
(15) 2822-2829 [2024-08-07; online 2024-07-29]
Spatial Mass Spectrometry [Collaborative]
PubMed
DOI
Crossref
Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson's disease primate model.
Kaya I, Nilsson A,
Luptáková D
, ...,
Bezard E
,
Andrén PE
NPJ Parkinsons Dis
9
(1) 118 [2023-07-26; online 2023-07-26]
Spatial Mass Spectrometry [Technology development]
PubMed
DOI
Crossref
Region-Specific and Age-Dependent Multitarget Effects of Acetylcholinesterase Inhibitor Tacrine on Comprehensive Neurotransmitter Systems.
Fridjonsdottir E,
Vallianatou T
, Mantas I, ..., Svenningsson P,
Andrén PE
ACS Chem. Biol.
17
(1) 147-158 [2022-01-21; online 2021-12-21]
Spatial Mass Spectrometry [Technology development]
PubMed
DOI
Crossref
Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood-brain barrier.
Luptáková D,
Vallianatou T
, Nilsson A, ...,
Loryan I
,
Andrén PE
Mol. Psychiatry
-
(-) - [2021-09-03; online 2021-09-03]
Spatial Mass Spectrometry [Technology development]
PubMed
DOI
Crossref
Integration of Mass Spectrometry Imaging and Machine Learning Visualizes Region-Specific Age-Induced and Drug-Target Metabolic Perturbations in the Brain.
Vallianatou T
,
Shariatgorji R
, Nilsson A, ..., Svenningsson P,
Andrén PE
ACS Chem Neurosci
12
(10) 1811-1823 [2021-05-19; online 2021-05-03]
Spatial Mass Spectrometry [Technology development]
PubMed
DOI
Crossref
Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia.
Fridjonsdottir E
,
Shariatgorji R
,
Nilsson A
, ...,
Bezard E
,
Andrén PE
Sci Adv
7
(2) - [2021-01-00; online 2021-01-06]
Spatial Mass Spectrometry [Technology development]
SciLifeLab Data Centre
Publications
9.5.1